These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21691281)

  • 21. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
    Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
    Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adjuvant vs. salvage radiotherapy after radical prostatectomy].
    Bartkowiak D; Schrader AJ; Wiegel T
    Aktuelle Urol; 2015 Jan; 46(1):52-8. PubMed ID: 25658231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [pT3R1 prostate cancer : Immediate or delayed radiotherapy after radical prostatectomy?].
    Bottke D; Wiegel T
    Urologe A; 2008 Nov; 47(11):1431-5. PubMed ID: 18810383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
    Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
    Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
    Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
    Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
    Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
    BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
    Viani GA; Hamamura AC; Correa AC; de Arruda FT
    Int Braz J Urol; 2019; 45(2):237-245. PubMed ID: 30676298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
    Stephenson AJ; Scardino PT; Kattan MW; Pisansky TM; Slawin KM; Klein EA; Anscher MS; Michalski JM; Sandler HM; Lin DW; Forman JD; Zelefsky MJ; Kestin LL; Roehrborn CG; Catton CN; DeWeese TL; Liauw SL; Valicenti RK; Kuban DA; Pollack A
    J Clin Oncol; 2007 May; 25(15):2035-41. PubMed ID: 17513807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.
    Raldow A; Hamstra DA; Kim S; Yu JB
    Oncology (Williston Park); 2010 Jul; 24(8):692-700, 702. PubMed ID: 20718248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer.
    Bartkowiak D; Siegmann A; Böhmer D; Budach V; Wiegel T
    BJU Int; 2019 Nov; 124(5):785-791. PubMed ID: 31220400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage radiation therapy following radical prostatectomy. A national Danish study.
    Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M
    Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.
    Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M
    Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
    Wiegel T; Bartkowiak D; Bottke D; Bronner C; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Stöckle M; Rübe C; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hofmann R; Engenhart-Cabillic R; Hinke A; Hinkelbein W; Miller K
    Eur Urol; 2014 Aug; 66(2):243-50. PubMed ID: 24680359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
    Siegmann A; Bottke D; Faehndrich J; Lohm G; Miller K; Bartkowiak D; Wiegel T; Hinkelbein W
    Strahlenther Onkol; 2011 Aug; 187(8):467-72. PubMed ID: 21786112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: a decision analysis.
    Parikh R; Sher DJ
    Cancer; 2012 Jan; 118(1):258-67. PubMed ID: 21720990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer: Systemic review and meta-analysis of 5-year and 10-year follow-up data.
    Ku JY; Lee CH; Ha HK
    Korean J Urol; 2015 Nov; 56(11):735-41. PubMed ID: 26568790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis.
    Showalter TN; Foley KA; Jutkowitz E; Lallas CD; Trabulsi EJ; Gomella LG; Dicker AP; Pizzi LT
    Ann Oncol; 2012 Mar; 23(3):701-706. PubMed ID: 21659666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
    Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
    Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.